pharmaceutical investing FDA Approves SEYSARA (Sarecycline) for the Treatment of Moderate to Severe Acne
pharmaceutical investing Paratek Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Omadacycline New Drug Applications
LaFleur Minerals Closes $1.66 Million Flow-Through Offering to Advance Drilling and PEA-Related Work at its Swanson Gold Deposit
